CN101843673B - Chinese medicament for treating arteriosclerosis - Google Patents

Chinese medicament for treating arteriosclerosis Download PDF

Info

Publication number
CN101843673B
CN101843673B CN2009102371128A CN200910237112A CN101843673B CN 101843673 B CN101843673 B CN 101843673B CN 2009102371128 A CN2009102371128 A CN 2009102371128A CN 200910237112 A CN200910237112 A CN 200910237112A CN 101843673 B CN101843673 B CN 101843673B
Authority
CN
China
Prior art keywords
chinese medicine
parts
chinese
chinese medicament
fine powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009102371128A
Other languages
Chinese (zh)
Other versions
CN101843673A (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rugao Jun Zhang Electronics Co Ltd
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2009102371128A priority Critical patent/CN101843673B/en
Publication of CN101843673A publication Critical patent/CN101843673A/en
Application granted granted Critical
Publication of CN101843673B publication Critical patent/CN101843673B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a Chinese medicament for treating arteriosclerosis and belongs to the field of Chinese medicaments for treating cardio-cerebral-vascular system diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: sandalwood, Chinese angelica, radix pseudo-ginseng, white paeony root and lucid ganoderma. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis and softening blood vessels, and has the advantages of obvious effect, exact medicinal effect and quick response.

Description

一种治疗动脉硬化的中药A traditional Chinese medicine for treating arteriosclerosis

技术领域technical field

本发明属于治疗心脑血管系统疾病的中药领域。The invention belongs to the field of traditional Chinese medicine for treating diseases of the cardiovascular and cerebrovascular systems.

背景技术Background technique

现有的用于治疗动脉硬化的中药,存在一些突出的问题:就是治疗效果不够明显,见效比较迟缓,以致于许多动脉硬化患者希望用中药长期调养治疗,而又找不到效果确切、疗效显著的中药,对此患者多有不满意。Existing traditional Chinese medicines for treating arteriosclerosis have some outstanding problems: the therapeutic effect is not obvious enough, and the effect is relatively slow, so that many patients with arteriosclerosis hope to use traditional Chinese medicine for long-term care and treatment, but they cannot find a definite and significant effect. Many patients are dissatisfied with traditional Chinese medicine.

针对以上提出的问题,本发明提供一种治疗动脉硬化的中药,它能解决以往此类中药效果不够明显,见效比较迟缓的问题,效果好、见效快,具有效果显著,药效确切,见效较快的优点。In view of the problems raised above, the present invention provides a traditional Chinese medicine for the treatment of arteriosclerosis, which can solve the problem that the effect of such traditional Chinese medicines is not obvious enough in the past, and the effect is relatively slow. The advantage of being fast.

发明内容Contents of the invention

本发明是通过以下技术方案来实现的:The present invention is achieved through the following technical solutions:

1、一种治疗动脉硬化的中药,采用中药原料制备,配方为(按重量比):1, a kind of Chinese medicine for the treatment of arteriosclerosis, adopts Chinese medicine raw material to prepare, and formula is (by weight):

檀香4-30份        当归4-30份        三七3-20份Sandalwood 4-30 parts Angelica 4-30 parts Panax notoginseng 3-20 parts

白芍4-30份        灵芝2-12份Paeoniae Alba 4-30 parts Ganoderma lucidum 2-12 parts

这种治疗动脉硬化的中药是由下列方法制成的:This traditional Chinese medicine for arteriosclerosis is made by the following methods:

(1)按上述重量比,将檀香、当归、白芍经常规水提取工艺提取,制成浸膏细粉;(1) according to the above weight ratio, sandalwood, angelica, Radix Paeoniae Alba are extracted through a conventional water extraction process to make extract powder;

(2)按上述重量比,将三七、灵芝分别研成细粉,与上述浸膏细粉混合,搅拌均匀;根据需要,可制成中药冲剂、颗粒剂、散剂、胶囊剂、水丸剂、片剂等剂型。(2) According to the above weight ratio, grind Panax notoginseng and Ganoderma lucidum into fine powder respectively, mix with the above-mentioned extract powder, and stir evenly; as required, it can be made into Chinese medicine granules, granules, powders, capsules, water pills, Dosage forms such as tablets.

本发明是根据民间传统配方,根据中医扶正培本、活血化瘀的理论,精心研制而成。方中灵芝、白芍扶正培本,益气养血,养心安神,增强机体免疫力;当归、三七养血活血化瘀,灵芝、白芍与当归、三七配伍,气旺血足,有利于血液循环和软化血管;辅以檀香芳香化浊,温通散寒。诸药配伍,相得益彰,共奏扶正培本,益气养血,活血化瘀,软化血管之功,效果好,见效快,具有效果显著,药效确切,见效较快的优点。The present invention is elaborately developed according to the folk traditional formula and the theory of traditional Chinese medicine of strengthening the body and strengthening the body, promoting blood circulation and removing blood stasis. In the prescription, Ganoderma lucidum and white peony root up the body, nourish qi and blood, nourish the heart and calm the nerves, and enhance the body's immunity; Angelica and Sanqi nourish blood, promote blood circulation and remove blood stasis, Ganoderma lucidum and white peony are compatible with angelica and Sanqi, the qi is vigorous and the blood is full, It is beneficial to blood circulation and softens blood vessels; it is supplemented with sandalwood to aromatize turbidity, warm and dispel cold. All the medicines are compatible and complement each other, and they play the functions of strengthening the body, nourishing qi and nourishing blood, promoting blood circulation and removing blood stasis, and softening blood vessels. The effect is good, and the effect is quick.

具体实施方式Detailed ways

通过以下实施方式对本发明做具体说明:The present invention is specifically described by the following embodiments:

1、取以下配方(重量按克为单位):1. Take the following formula (weight is in grams):

檀香80克        当归80克        三七60克Sandalwood 80g Angelica 80g Panax notoginseng 60g

白芍80克        灵芝40克Paeoniae Alba 80g Ganoderma lucidum 40g

按规定重量,用常规水提取工艺将檀香、当归、白芍提取,制成浸膏细粉72克,将三七、灵芝分别研成细粉,与上述浸膏细粉混合,搅拌均匀,制成细小颗粒,装入0号胶囊,制成中药胶囊614粒,每粒胶囊内含中药细粉及提取物0.28克。According to the specified weight, sandalwood, angelica, and white peony are extracted with conventional water extraction process to make 72 grams of extract powder, and Sanqi and Ganoderma lucidum are respectively ground into fine powder, mixed with the above extract powder, and stirred evenly. Make fine particles, pack into No. 0 capsules, and make 614 Chinese medicine capsules, each capsule contains Chinese medicine fine powder and 0.28 grams of extract.

2、取以下配方(重量按克为单位):2. Take the following formula (weight is in grams):

檀香160克        当归160克        三七90克Sandalwood 160g Angelica 160g Sanqi 90g

白芍160克        灵芝60克Paeoniae Alba 160g Ganoderma lucidum 60g

按上述同样的方法,制成中药胶囊1050粒,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, make 1050 Chinese medicine capsules, each capsule contains Chinese medicine fine powder and extract 0.28 gram.

3、取以下配方(重量按克为单位):3. Take the following formula (the weight is in grams):

檀香300克        当归300克        三七200克Sandalwood 300g Angelica 300g Sanqi 200g

白芍300克        灵芝120克Paeoniae Alba 300g Ganoderma lucidum 120g

按上述同样的方法,制成中药胶囊2107粒,每粒胶囊内含中药细粉及提取物0.28克。By above-mentioned same method, make 2107 Chinese medicine capsules, every capsule contains Chinese medicine fine powder and extract 0.28 gram.

4、取以下配方(按重量比):4. Take the following formula (by weight):

檀香8份        当归8份        三七6份Sandalwood 8 parts Angelica 8 parts Panax notoginseng 6 parts

白芍8份        灵芝4份8 parts of white peony root 4 parts of Ganoderma lucidum

按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.

5、取以下配方(按重量比):5. Take the following formula (by weight):

檀香20份        当归20份        三七15份Sandalwood 20 parts Angelica 20 parts Panax notoginseng 15 parts

白芍20份        灵芝8份20 parts of white peony root 8 parts of Ganoderma lucidum

按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.

临床资料:clinical information:

本发明以中医动脉硬化为例,经7例临床观察。选择中医诊断动脉硬化为标准:体质虚弱,肢软乏力,心慌、心悸、气紧,心律增至120次/分钟左右,头晕眼花,睡眠欠佳,四肢发麻,心肌缺血。如上症状,即可确诊。在确诊观察的对象中,男性4例,女性3例,无其它严重疾病,年龄为42岁-79岁,平均年龄66.4岁。The present invention takes TCM arteriosclerosis as an example, through 7 clinical observations. TCM diagnosis of arteriosclerosis was selected as the standard: physical weakness, limb weakness, palpitation, palpitation, shortness of breath, heart rate increased to about 120 beats/min, dizziness, poor sleep, numb limbs, myocardial ischemia. The above symptoms can be diagnosed. Among the confirmed observation objects, there were 4 males and 3 females, without other serious diseases, aged from 42 to 79 years old, with an average age of 66.4 years.

疗效判定:Judgment of curative effect:

1、显效:体质增强,身上有劲,心慌、心悸、气紧,心动过速,肢体麻木,心肌缺血,睡眠欠佳等症状明显缓解。1. Significant effect: Physical fitness is enhanced, body is strong, palpitation, heart palpitations, shortness of breath, tachycardia, numbness of limbs, myocardial ischemia, poor sleep and other symptoms are significantly relieved.

2、有效:体质增强,心慌、心悸、气紧,麻木等症状有所缓解。2. Effective: Physical fitness is enhanced, and symptoms such as palpitation, heart palpitations, tightness of breath, and numbness are relieved.

3、无效:病症无变化。3. Ineffective: no change in symptoms.

临床实验时,停服其它药物和保健营养品。服用本发明中药胶囊,观察3个月,为一个疗程。服用方法:每日2次,每次4粒胶囊,每粒胶囊内含中药细粉及提取物0.28克,饭后温开水送服,30天后症状即有缓解,服用3个月后,症状明显改善。临床实验的7人中,显效3人,有效3人,无效1人,总有效率85.7%。During the clinical trial, stop taking other medicines and health nutrition products. Take Chinese medicine capsule of the present invention, observe 3 months, be a course of treatment. Dosing method: 2 times a day, 4 capsules each time, each capsule contains 0.28g of fine powder and extract of traditional Chinese medicine, take it with warm water after meals, the symptoms will be relieved after 30 days, and the symptoms will be obvious after taking it for 3 months improve. Among the 7 people in the clinical trial, 3 people were markedly effective, 3 people were effective, and 1 person was ineffective, and the total effective rate was 85.7%.

Claims (1)

1. the arteriosclerotic Chinese medicine of treatment is characterized in that, described Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Lignum Santali Albi 4---20 parts of 30 parts of Radix Angelicae Sinensis 4---30 portions of Radix Notoginseng 3---
12 parts of the Radix Paeoniae Albas 4---30 portions of Ganodermas 2---
The arteriosclerotic Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, Lignum Santali Albi, Radix Angelicae Sinensis, the Radix Paeoniae Alba are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; Make Chinese medicine granules, capsule, watered pill, Tabules.
CN2009102371128A 2009-11-04 2009-11-04 Chinese medicament for treating arteriosclerosis Expired - Fee Related CN101843673B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009102371128A CN101843673B (en) 2009-11-04 2009-11-04 Chinese medicament for treating arteriosclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009102371128A CN101843673B (en) 2009-11-04 2009-11-04 Chinese medicament for treating arteriosclerosis

Publications (2)

Publication Number Publication Date
CN101843673A CN101843673A (en) 2010-09-29
CN101843673B true CN101843673B (en) 2011-07-20

Family

ID=42768609

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009102371128A Expired - Fee Related CN101843673B (en) 2009-11-04 2009-11-04 Chinese medicament for treating arteriosclerosis

Country Status (1)

Country Link
CN (1) CN101843673B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1287006A (en) * 1999-09-08 2001-03-14 王化忠 Chinese medicine powder for treating hypertension and arteriosclerosis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1287006A (en) * 1999-09-08 2001-03-14 王化忠 Chinese medicine powder for treating hypertension and arteriosclerosis

Also Published As

Publication number Publication date
CN101843673A (en) 2010-09-29

Similar Documents

Publication Publication Date Title
CN101843787B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843699B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843661B (en) Chinese medicament for treating angina
CN101843712B (en) Chinese medicament for treating angina
CN101843660B (en) Chinese medicament for treating tachycardia
CN101843829B (en) Chinese medicament for treating pulmonary heart diseases
CN101537121B (en) Chinese medicine for treating arteriosclerosis
CN101843753B (en) Chinese medicament for treating angina
CN101843673B (en) Chinese medicament for treating arteriosclerosis
CN101850015B (en) Chinese medicament for treating arteriosclerosis
CN101843672B (en) Chinese medicament for treating arteriosclerosis
CN101843717B (en) Chinese medicament for treating coronary disease
CN101843645B (en) Chinese medicament for treating tachycardia
CN101843720B (en) Chinese medicament for treating angina
CN101843793B (en) Chinese medicament for treating tachycardia
CN101849985B (en) Chinese medicament for treating tachycardia
CN101843700A (en) Chinese medicament for treating coronary disease
CN101843835B (en) Chinese medicament for treating coronary diseases
CN101843796A (en) Chinese medicament for treating pulmonary heart diseases
CN101879259B (en) Traditional Chinese medicine for treating pulmonary heart diseases
CN101843831B (en) Chinese medicament for treating diabetic cardiopathy
CN101843798B (en) Oral Chinese medicament for treating fracture
CN101850033A (en) A traditional Chinese medicine for treating arteriosclerosis
CN101843750B (en) Chinese medicament for treating chronic nephritis
CN101843646A (en) Chinese medicament for treating tachycardia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: RUGAO JUNZHANG ELECTRONICS CO., LTD.

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20130809

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20130809

Address after: Zhu Yao Cun Bai Pu Zhen 226500 Jiangsu city of Rugao Province in 18 groups

Patentee after: Rugao Jun Zhang Electronics Co., Ltd.

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110720

Termination date: 20171104

CF01 Termination of patent right due to non-payment of annual fee